IP Library Granted Patent US 9,885,712
Granted Patent B2
US 9,885,712 · App. 14/081,158 · Granted Feb 6, 2018

Calibrating assays using reaction time

Inventors: Zhong Ding (Pittsford, NY); Edward R. Scalice (Penfield, NY)
Assignee: Ortho-Clinical Diagnostics, Inc.
G01N33/557G01N33/5302G01N33/543G01N33/54306G01N33/558B01L2300/0825Y10T436/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,885,712
App. No.
14/081,158
Granted
Feb 6, 2018
Kind
B2
Abstract

A method for performing an assay on a liquid sample for the detection of one or more analytes of interest in an assay device having a flow path which includes a sample zone and detection zone thereon includes: dispensing the sample onto the sample zone; combining the sample and a reagent, wherein the sample and reagent may be combined prior to addition of the sample to the sample zone or on the assay device, flowing the combined sample/reagent by capillary action into and through the detection zone having capture elements bound thereto, wherein a signal at least partially representative of the presence or concentration of analyte(s) is produced and detected; determining a reaction time or reaction volume; and determining the concentration of the analyte by using both the detected signal and the reaction time or reaction volume.

Claims (9)

1. A method for performing an assay on a liquid sample for the detection of one or more analytes of interest in an assay device having a flow path which includes a sample zone, a reagent zone, a detection zone and a wicking zone disposed thereon, wherein the method comprises:

dispensing the liquid sample onto the sample zone of the assay device, wherein the liquid sample is caused to flow under capillary action along the flow path;

combining the sample and a reagent, wherein the sample and reagent may be combined prior to addition of the liquid sample to the sample zone or on the assay device in the reagent zone, the reagent being capable of reacting with the one or more analytes in the flowing liquid sample and creating a combined sample/reagent containing a detection element,

flowing the combined sample/reagent by capillary action into and through the detection zone having capture elements bound thereto for binding the one or more analytes such that the combined sample/reagent is retained and detected in the detection zone, wherein a signal at least partially representative of the presence or concentration of the one or more analyte(s) is produced through the detection element that is either associated with the reagent or with the combined sample/reagent generated through a reaction involving the reagent and detected by a detection instrument disposed in relation to the detection zone;

determining a reagent dissolution time based on a first time point when the signal is first detected at a point in the detection zone downstream of the reagent zone and a second time point in which the signal is no longer detected at said point;

determining a reaction volume which is the volume of sample flowing through the reagent zone during the determined reagent dissolution time;

obtaining a detection signal indicative of the concentration of the one or more analytes of interest by using the detection instrument to detect the signal at least partially representative of the presence or concentration of the one or more analyte(s); and

adjusting the detection signal by multiplying the obtained detection signal by the reaction volume.

2. The method as claimed in claim 1 , wherein the reaction volume is the product of reagent dissolution time and flow rate.

Assignments (6)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2014
From: DING, ZHONG; SCALICE, EDWARD R.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 031935/0015 →
Continuity (1)
Related Publication 20140134653A1 · May 15, 2014